Dartsch P C, Voisard R, Betz E
Institute of Physiology I, University of Tübingen, Federal Republic of Germany.
Res Exp Med (Berl). 1990;190(2):77-87. doi: 10.1007/pl00020009.
Cell size distribution and growth rates were studied in vitro in human plaque cells from advanced primary stenosing and fresh restenosing lesions of peripheral and coronary arteries. Cells were isolated either by the explant technique or by enzymatic disaggregation and were identified as smooth muscle cells by their typical growth pattern and their positive reaction with antibodies against smooth muscle alpha-actin. Endothelial cells were found in plaque specimens from coronary arteries but were only present in primary cultures. Smooth muscle cells from primary stenosing tissue (ps-SMC) exhibited a significantly lower growth rate in culture (0.15 +/- 0.04 population doublings per day; means +/- SD) compared with cells from restenosing lesions (re-SMC; 0.60 +/- 0.13 population doublings per day; means +/- SD). ps-SMC usually became senescent in their second passage, i.e., after 5-7 cumultive population doublings. re-SMC retained their high proliferative activity even after five passages (15 cumulative population doublings). Cell populations of both origins consisted of two distinct subpopulations which could be discriminated by cell size measurements: relatively small, predominant cells (cell diameter: 18.0 +/- 4 microns; means +/- SD) and large fibroblast-like cells (cell diameter: 26.0 +/- 3 microns; means +/- SD). The proportion of large cells was higher in cell populations derived from primary stenosing tissue. These results suggest that stenosing plaque tissue from human peripheral and coronary arteries consists of two smooth muscle cell subpopulations. The low proliferative activity of total smooth muscle cell populations of advanced primary stenosing lesions contrasts with the high mitotic activity of smooth muscle cells obtained from secondary stenosing intimal proliferates.
在体外研究了来自外周和冠状动脉晚期原发性狭窄病变及新鲜再狭窄病变的人斑块细胞的细胞大小分布和生长速率。细胞通过外植体技术或酶解聚分离,并通过其典型的生长模式以及与抗平滑肌α-肌动蛋白抗体的阳性反应鉴定为平滑肌细胞。在冠状动脉斑块标本中发现了内皮细胞,但仅存在于原代培养物中。与来自再狭窄病变的细胞(re-SMC;每天0.60±0.13个群体倍增;平均值±标准差)相比,原发性狭窄组织的平滑肌细胞(ps-SMC)在培养中的生长速率显著较低(每天0.15±0.04个群体倍增;平均值±标准差)。ps-SMC通常在第二次传代时衰老,即经过5-7次累积群体倍增后。即使经过五次传代(15次累积群体倍增),re-SMC仍保持其高增殖活性。两种来源的细胞群体均由两个不同的亚群组成,可通过细胞大小测量加以区分:相对较小的优势细胞(细胞直径:18.0±4微米;平均值±标准差)和较大的成纤维细胞样细胞(细胞直径:26.0±3微米;平均值±标准差)。来自原发性狭窄组织的细胞群体中较大细胞的比例更高。这些结果表明,人外周和冠状动脉的狭窄斑块组织由两个平滑肌细胞亚群组成。晚期原发性狭窄病变的总平滑肌细胞群体的低增殖活性与从继发性狭窄内膜增殖物中获得的平滑肌细胞的高有丝分裂活性形成对比。